INHALATION DEVICE FOR USE IN AEROSOL THERAPY OF RESPIRATORY DISEASES

(19)

(11)

EP 3 204 095 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	10.07.2019 Bulletin 2019/28

(45)	Mention of the grant of the patent:
	29.05.2019 Bulletin 2019/22

(21)	Application number: 15778328.3

(22)	Date of filing: 09.10.2015

(51)

International Patent Classification (IPC):

A61K 39/395^(2006.01)
A61K 45/06^(2006.01)
C07K 16/10^(2006.01)
A61M 11/00^(2006.01)
A61M 15/06^(2006.01)
A61M 15/02^(2006.01)
A61K 9/00^(2006.01)
A61M 16/00^(2006.01)

A61K 39/42^(2006.01)
A61K 47/10^(2017.01)
A61K 39/00^(2006.01)
A61M 15/00^(2006.01)
A61M 11/04^(2006.01)
A61M 16/20^(2006.01)
A61K 47/26^(2006.01)

(86)	International application number:
	PCT/EP2015/073486

(87)	International publication number:
	WO 2016/055655 (14.04.2016 Gazette 2016/15)

(54)	INHALATION DEVICE FOR USE IN AEROSOL THERAPY OF RESPIRATORY DISEASES INHALATIONSVORRICHTUNG ZUR VERWENDUNG IN EINER AERORSOLTHERAPIE FÜR ATEMWEGSERKRANKUNGEN DISPOSITIF D'INHALATION POUR UTILISATION DANS UNE THÉRAPIE PAR AÉROSOL DE MALADIES RESPIRATOIRES

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

10.10.2014 US 201462062469 P
22.10.2014 US 201462067096 P
04.11.2014 US 201462074842 P
13.11.2014 EP 14193094

(43)	Date of publication of application:
	16.08.2017 Bulletin 2017/33

(73)	Proprietors:
	Ablynx N.V. 9052 Ghent-Zwijnaarde (BE) Vectura GmbH 82131 Gauting (DE)

(72)	Inventors:
	ALLOSERY, Koen 8400 Oostende (BE) HUBER, Martin 82131 Gauting (DE) KOLB, Tobias 82131 Gauting (DE) MÜLLINGER, Bernhard 82131 Gauting (DE) SCHICK, Juliane 82131 Gauting (DE) DEPLA, Erik 9070 Destelbergen (BE)

(74)	Representative: CMS Cameron McKenna Nabarro Olswang LLP
	Cannon Place 78 Cannon Street London EC4N 6AF London EC4N 6AF (GB)

(56)

References cited: :

EP-A1- 1 908 489
WO-A1-2013/098334
US-A1- 2012 167 878
US-A1- 2013 019 860
US-A1- 2014 020 680

WO-A1-2013/067164
WO-A1-2013/132056
US-A1- 2013 008 436
US-A1- 2013 104 887

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).